Patient P-01770

Synthetic patientNBL-101 · Day 109 · 35–44 · M · baseline S13Steering view · 3D Open companion preview

Therapy response

Favorable

Tolerance

Deteriorating

GI state

Deteriorating

Inflammatory state

Deteriorating

Nutritional resilience

Declining

Discontinuation risk

28%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events

solid = observed · dashed = predicted

Day 0 NBL-101 started — Baseline state S13

What changed?

Trajectory is tracking the baseline prediction.

Primary contributors, last 14 days

Nutritional resilience-16
GI instability+12
Inflammatory activity+9
Toxicity+8

What helped?

No interventions yet.

LIFE OS recommendation

No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

GI burden

Companion

20.1/100

worsening · +2.4 vs previous 14 d

Toxicity

Blood

13.8/100

worsening · +3.7 vs previous 14 d

Sleep quality

Wearable

40.4/100

worsening · -3.0 vs previous 14 d

Energy level

Daily log

5.8/10

stable · -0.0 vs previous 14 d

Stress level

Daily log

4.2/10

stable · -0.1 vs previous 14 d

Steps

Wearable

4,190

worsening · -262 vs previous 14 d

Adherence

Companion

90.3 %

stable · +0.7 vs previous 14 d

This trajectory is decaying — what would help, what would not

Steering view →

Heading towards failing · 87 from the failing basin, 4 from restoration.

Would help

No untried action with strong evidence. Compose one from primitives.

Would not help

Keep simple carbs low
GI +3.8 next day on high-intake days · n 19

State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

Simple carbohydrates
+3.8detractor · 89%
Dietary fat load
+2.4no signal · 53%
Histamine load
-2no signal · 45%
Spicy / capsaicin
+1.9no signal · 44%
Insoluble fibre
-0.4no signal · 15%
Alcohol
-0.2no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure

Mucosal barrier integrity ↓30
- MicrobiomeAkkermansia low → thinner mucus layer
Butyrate / short-chain fatty acid production ↓25
- MicrobiomeF. prausnitzii depleted
Inflammatory signalling ↑15
- WearableHRV 34 ms, trending down

DNA

Fictional pharmacogenomic panel

CYP2D6 Normal metabolizer
Expected exposure

Microbiome

Shannon diversity 2.8 · butyrate capacity 52/100

Akkermansia muciniphilaLow
Faecalibacterium prausnitziiLow
Bacteroides fragilisNormal
Bifidobacterium longumNormal
EnterobacteriaceaeNormal

Wearable, last 14 days

daily evolution fed into the runtime

HRV: 39 ms
Sleep: 7.4 h
Steps: 5,215
Resting HR: 69 bpm

Daily log: GI score 20, nutritional resilience 61, adherence 90.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview

What to eat

Keep meals regular; three to four moderate portions spaced through the day
Include a cooked vegetable portion with each main meal
Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
Avoid known triggers for now: fried or oily food, dairy, alcohol

What to do

Log the daily check-in; one line is enough
A 15-minute walk after lunch
Keep the sleep window steady
Keep hydration steady: small amounts through the day rather than large volumes at once

What to take

Take the scheduled dose as agreed with your care team
No additional supplements this week
Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

Patient	Similarity	Baseline	Intervention	Outcome	Response today
P-01766	38%	S05	AD-05	no change	90
P-01804	33%	S19	AD-05	improved	61
P-01329	40%	S08	BR-03	improved	79
P-01495	39%	S07	BR-03	improved	85
P-01677	37%	S05	BR-03	no change	86
P-01654	45%	S08	CR-01	improved	85
P-01430	29%	S05	CR-01	improved	54
P-01767	34%	S14	DT-01	no change	63
P-01855	33%	S04	DT-01	improved	73
P-01479	32%	S15	DT-01	improved	84
P-01724	30%	S10	DT-01	improved	63
P-01346	29%	S12	DT-01	improved	52